Mario Zoratti Selected Research

5-(4-phenylbutoxy)psoralen

1/2017	Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells.
7/2012	Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Zoratti Research Topics

Disease

20	Neoplasms (Cancer) 01/2021 - 07/2005
3	Melanoma (Melanoma, Malignant) 01/2021 - 07/2012
2	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2015
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 05/2009
2	Obesity 07/2017 - 01/2017
2	Insulin Resistance 07/2017 - 01/2014
2	Adenocarcinoma 06/2017 - 01/2017
1	Multiple Myeloma 04/2022
1	Leukemia 02/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Cognitive Dysfunction 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Leprosy (Hansen's Disease) 06/2017
1	Autoimmune Diseases (Autoimmune Disease) 06/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Glioma (Gliomas) 01/2017
1	Spastic Paraplegia Type 7 10/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2014
1	Infections 01/2007
1	Gastritis 01/2007
1	Carcinoma (Carcinomatosis) 07/2005
1	Cystic Fibrosis (Mucoviscidosis) 12/2002

Drug/Important Bio-Agent (IBA)

6	Potassium Channels (Potassium Channel)IBA 02/2022 - 05/2009
5	Ion Channels (Ion Channel)IBA 01/2021 - 09/2013
5	Proteins (Proteins, Gene)FDA Link 01/2014 - 12/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 01/2017
3	Clofazimine (Lamprene)FDA Link 06/2017 - 07/2012
2	Kv1.3 Potassium ChannelIBA 04/2022 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 06/2017
2	pterostilbeneIBA 01/2019 - 07/2017
2	5-(4-phenylbutoxy)psoralenIBA 01/2017 - 07/2012
2	AnionsIBA 06/2016 - 12/2002
1	venetoclaxIBA 04/2022
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2021
1	PyocyanineIBA 01/2021
1	flopropioneIBA 01/2021
1	CateninsIBA 01/2019
1	PorinsIBA 01/2019
1	Voltage-Dependent Anion ChannelsIBA 01/2019
1	Furocoumarins (Furanocoumarins)IBA 01/2018
1	QuercetinIBA 10/2017
1	Phosphotransferases (Kinase)IBA 10/2017
1	Glycerol (Glycerine)FDA LinkGeneric 07/2017
1	AdipokinesIBA 07/2017
1	CarbamatesIBA 07/2017
1	Triglycerides (Triacylglycerol)IBA 07/2017
1	Peptide Hydrolases (Proteases)FDA Link 10/2016
1	SodiumIBA 06/2016
1	PotassiumIBA 06/2016
1	CalciumIBA 06/2016
1	alpha-Tocopherol FDA Link 04/2015
1	Mitochondrial DNA (mtDNA)IBA 04/2015
1	Succinic Acid (Succinate)IBA 04/2015
1	Messenger RNA (mRNA)IBA 01/2014
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2014
1	TeaIBA 01/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2005
1	Etoposide (VP 16)FDA LinkGeneric 07/2005
1	Mitochondrial Permeability Transition PoreIBA 07/2005
1	StaurosporineIBA 07/2005

Therapy/Procedure

6	Therapeutics 04/2022 - 11/2010
1	Heterologous Transplantation (Xenotransplantation) 06/2017
1	Lasers (Laser) 01/2014
1	Intraperitoneal Injections 07/2012